Abstracts tagged "Antiphospholipid antibodies and systemic sclerosis"

Abstract Number: 1893 • 2016 ACR/ARHP Annual Meeting
Prevalence of Antiphospholipid Antibodies in Systemic Sclerosis: A Systematic Review and Meta-Analysis
Angélique Lemaire^1,2, Vincent Sobanski^2,3,4,5, Luc Dauchet⁶, Eric Hachulla^1,2,3,5, Sylvain Dubucquoi^3,5,7, Marc Lambert^1,2,3,5, Pierre-Yves Hatron^1,2,8 and David Launay^1,2,3,5, ¹CHU Lille, Département de Médecine Interne et Immunologie Clinique, F-59000 Lille, France, Lille, France, ²CHU Lille, Centre national de référence maladies systémiques et auto-immunes rares (sclérodermie systémique), F-59000 Lille, France, Lille, France, ³Inserm, U995, F-59000 Lille, France, Lille, France, ⁴CHU Lille, Département de Médecine Interne et Immunologie Clinique, F-59000 Lille, France, ⁵Univ. Lille, U995, Lille Inflammation Research International Center (LIRIC), F-59000 Lille, France, Lille, France, ⁶CHU Lille, Service d’Epidémiologie, économie de la santé et prevention, F-59000 Lille, France, Lille, France, ⁷CHU Lille, Laboratoire d’Immunologie, F-59000 Lille, France, Lille, France, ⁸Univ Lille, CHU Lille, F-59000 Lille, France, Lille, France
Background/Purpose: Antiphospholipid antibodies (aPL) can be present in the sera of systemic sclerosis (SSc) patients. Important variations of their prevalence are observed in the literature.…